Chemical pricing pilot
Analytics and sales leaders distrust each other. Who should own the pricing decision?
Decision owner:Chief commercial officer / pricing owner
Complete operation film
What you are being asked to decideMass pricing ignored product, customer, and regional differences, while frontline overrides were not structured data.
Cost of getting it wrongChoosing either side too early can scale bad prices—or preserve unmeasurable exceptions and margin leakage.
Marcus · DecisionReject the human-versus-algorithm choice; design a bounded joint pilot.
Evelyn · Evidence & riskWithout override reasons and churn attribution, either side can reinterpret the result.
Sofia · Stakeholder impactA small noncritical customer set limits commercial harm while building shared evidence.
Minerva Team's provisional judgmentWithout structured override reasons and attribution of churn causes, any pilot result can be misread—regardless of the chosen design.Pilot analytics plus frontline review on 1–2 product lines and a small group of noncritical customers—without a broad price change.
The question only you can resolveCan every frontline override be captured with a reason before the pilot starts?
Watch the complete operation film →
See why the Minerva Team reached this judgment
Selected methodsConflict map + root-cause analysis
What would reverse itPause the pilot if override reasons and price/service/competition churn attribution are not available before launch.
Official public sourceMcKinsey & Company · chemical pricing case study
Analysis work receipt
1official source6model calls10/10decision checks113.6actual runtime